Interpace Biosciences, Inc.
IDXG
$1.14
-$0.03-2.56%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.46M | 2.11M | 2.02M | 2.81M | 3.50M |
| Total Receivables | 8.54M | 7.29M | 6.21M | 5.01M | 5.08M |
| Inventory | 1.21M | 1.22M | 1.23M | 1.15M | 1.23M |
| Prepaid Expenses | 535.00K | 441.00K | 667.00K | 387.00K | 590.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 22.00K | 43.00K | 43.00K | 57.00K | 24.00K |
| Total Current Assets | 11.77M | 11.11M | 10.17M | 9.42M | 10.42M |
|
|
|||||
| Total Current Assets | 11.77M | 11.11M | 10.17M | 9.42M | 10.42M |
| Net Property, Plant & Equipment | 2.97M | 2.88M | 2.76M | 2.68M | 2.65M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 45.00K | 45.00K | 45.00K | 45.00K | 45.00K |
| Total Assets | 14.79M | 14.04M | 12.97M | 12.14M | 13.12M |
|
|
|||||
| Total Accounts Payable | 1.66M | 1.70M | 1.76M | 1.36M | 1.54M |
| Total Accrued Expenses | 3.33M | 10.16M | 9.17M | 8.55M | 3.01M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.67M | 5.99M | 7.10M | 7.87M | 5.48M |
| Total Finance Division Other Current Liabilities | 957.00K | 919.00K | 998.00K | 1.18M | 1.41M |
| Total Other Current Liabilities | 957.00K | 919.00K | 998.00K | 1.18M | 1.41M |
| Total Current Liabilities | 10.62M | 18.77M | 19.03M | 18.97M | 11.44M |
|
|
|||||
| Total Current Liabilities | 10.62M | 18.77M | 19.03M | 18.97M | 11.44M |
| Long-Term Debt | -- | -- | -- | 1.34M | 4.24M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.18M | 1.19M | 1.29M | 1.36M | 1.47M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.21M | 5.23M | 5.15M | 5.07M | 4.97M |
| Total Liabilities | 17.01M | 25.19M | 25.46M | 26.75M | 22.12M |
|
|
|||||
| Common Stock & APIC | 235.22M | 188.77M | 188.68M | 188.63M | 188.55M |
| Retained Earnings | -235.38M | -244.41M | -245.69M | -247.75M | -242.08M |
| Treasury Stock & Other | -2.05M | -2.05M | -2.02M | -2.02M | -2.01M |
| Total Common Equity | -2.22M | -57.68M | -59.03M | -61.14M | -55.54M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | 46.54M | 46.54M | 46.54M | 46.54M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | 46.54M | 46.54M | 46.54M | 46.54M |
|
|
|||||
| Total Common Equity | -2.22M | -57.68M | -59.03M | -61.14M | -55.54M |
| Total Preferred Equity | -- | 46.54M | 46.54M | 46.54M | 46.54M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.22M | -11.15M | -12.49M | -14.61M | -9.00M |
|
|
|||||